Search

Your search keyword '"Shimano, Hitoshi"' showing total 1,201 results

Search Constraints

Start Over You searched for: Author "Shimano, Hitoshi" Remove constraint Author: "Shimano, Hitoshi"
1,201 results on '"Shimano, Hitoshi"'

Search Results

201. Oxidative stress and Liver X Receptor agonist induce hepatocellular carcinoma in Non‐alcoholic steatohepatitis model.

202. Hepatocellular carcinoma development in diabetic patients: a nationwide survey in Japan.

206. Overexpression of apolipoprotein E prevents development of diabetic hyperlipidemia in transgenic mice

211. The Peroxisome Proliferator-Activated Receptor α (PPARα) Agonist Pemafibrate Protects against Diet-Induced Obesity in Mice

214. Molecular association model of PPARα and its new specific and efficient ligand, pemafibrate: Structural basis for SPPARMα

216. Transgenic Mice Overexpressing SREBP-1a in Male ob/ob Mice Exhibit Lipodystrophy and Exacerbate Insulin Resistance

217. Saturated Fatty Acids Undergo Intracellular Crystallization and Activate the NLRP3 Inflammasome in Macrophages

221. Epigenetic modulation of Fgf21 in the perinatal mouse liver ameliorates diet-induced obesity in adulthood

222. A candidate functional SNP rs7074440 inTCF7L2alters gene expression through C-FOS in hepatocytes

223. A Rare Coexistence of Pheochromocytoma and Parkinson's Disease With Diagnostic Challenges

224. Quantitative Relationship Between Cumulative Risk Alleles Based on Genome-Wide Association Studies and Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis

226. Relationships among cardiorespiratory fitness, muscular fitness, and cardiometabolic risk factors in Japanese adolescents: Niigata screening for and preventing the development of non-communicable disease study-Agano (NICE EVIDENCE Study-Agano) 2

227. Novel non-alcoholic steatohepatitis model with histopathological and insulin-resistant features

228. Effect of sodium-glucose cotransporter 2 (SGLT2) inhibition on weight loss is partly mediated by liver-brain-adipose neurocircuitry

230. Elovl6 Deficiency Improves Glycemic Control in Diabetic db/db Mice by Expanding β-Cell Mass and Increasing Insulin Secretory Capacity

232. Selective peroxisome proliferator-activated receptor-α modulator K-877 efficiently activates the peroxisome proliferator-activated receptor-α pathway and improves lipid metabolism in mice

233. A key role of nuclear factor Y in the refeeding response of fatty acid synthase in adipocytes

234. Comparison of baseline characteristics and clinical course in Japanese patients with type 2 diabetes among whom different types of oral hypoglycemic agents were chosen by diabetes specialists as initial monotherapy (JDDM 42)

235. SREBP1 Contributes to Resolution of Pro-inflammatory TLR4 Signaling by Reprogramming Fatty Acid Metabolism

236. Role of Hormone-sensitive Lipase in Leptin-Promoted Fat Loss and Glucose Lowering

237. In vivo promoter analysis on refeeding response of hepatic sterol regulatory element-binding protein-1c expression

238. Elongation of Long‐Chain Fatty Acid Family Member 6 (Elovl6)‐Driven Fatty Acid Metabolism Regulates Vascular Smooth Muscle Cell Phenotype Through AMP‐Activated Protein Kinase/Krüppel‐Like Factor 4 (AMPK/KLF4) Signaling

239. CREB3L3 controls fatty acid oxidation and ketogenesis in synergy with PPARα

242. Intestinal CREBH overexpression prevents high-cholesterol diet-induced hypercholesterolemia by reducing Npc1l1 expression

243. Utility of nonblood-based risk assessment for predicting type 2 diabetes mellitus: A meta-analysis

247. KLF15 Enables Rapid Switching between Lipogenesis and Gluconeogenesis during Fasting

249. Different Effects of Eicosapentaenoic and Docosahexaenoic Acids on Atherogenic High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice

250. Hyperlipidemia and hepatitis in liver-specific CREB3L3 knockout mice generated using a one-step CRISPR/Cas9 system

Catalog

Books, media, physical & digital resources